Self-assembled hybrid elastin-like polypeptide/silica nanoparticles enable triggered drug release

Area of Science:

• Biomaterials Science
• Nanotechnology
• Biochemistry

Background:

• Biomimetic polypeptides facilitate the creation of hybrid materials with inorganic components.
• Applications include drug delivery, enzyme immobilization, and surface modification.

Purpose of the Study:

• To develop a method for creating hybrid polypeptide-silica nanoparticles for drug delivery.
• To demonstrate the encapsulation and controlled release of drugs from these nanoparticles.

Main Methods:

• Utilized self-assembling elastin-like polypeptides (ELPs) modified with silica-promoting sequences.
• Incorporated drug conjugates into the micellar core and silaffin peptide into the corona.
• Encapsulated micelles within a silica matrix via polycondensation.
• Demonstrated drug loading with a model small molecule and doxorubicin.

Main Results:

• Successfully formed uniform, hybrid polypeptide-silica nanoparticles.
• Showcased encapsulation of hydrophobic small molecules and doxorubicin.
• Demonstrated pH-dependent release of doxorubicin from the nanoparticles.

Conclusions:

• The developed hybrid nanoparticles offer a promising platform for targeted drug delivery.
• The pH-dependent release mechanism allows for controlled therapeutic agent administration.
• This approach integrates biomimetic design with nanotechnology for advanced material applications.